Evaluating a tool to assess heart health in cancer survivors
Assessing efficacy and implementation of an EHR tool to assess heart health among survivors
This study is testing a new tool to help cancer survivors keep their heart health in check, making it easier for both patients and doctors to spot and manage any heart risks related to cancer treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10810640 on NIH RePORTER |
What this research studies
This research focuses on improving cardiovascular health among cancer survivors by implementing an electronic health record (EHR) tool designed to assess heart health. The Automated Heart Health Application (AH-HA) will be used in primary care settings to evaluate cardiovascular risk factors and the potential cardiotoxic effects of cancer treatments. By increasing awareness and management of cardiovascular health, the study aims to reduce the risk of cardiovascular disease and cancer recurrence among survivors. The research will involve mixed methods to evaluate the effectiveness and usability of the tool among both patients and healthcare providers.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer survivors, particularly those who have received treatments known to have cardiotoxic effects and who may not have regular access to primary care.
Not a fit: Patients who are not cancer survivors or those who have not received cardiotoxic cancer treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better cardiovascular health management for cancer survivors, potentially reducing their risk of heart disease and improving overall survivorship outcomes.
How similar studies have performed: Previous research has shown promise in using EHR tools for health assessments, indicating that this approach could be effective in improving patient outcomes.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Weaver, Kathryn Elizabeth — Wake Forest University Health Sciences
- Study coordinator: Weaver, Kathryn Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.